Last reviewed · How we verify
NCT03752060
The Clinical Utility of Resistance Training for Improving Cardiovascular Disease Risk in Post-Menopausal Women
NA trial testing Resistance Exercise in Cardiovascular Risk Factor in 68 participants. Completed in 22 November 2019.
15 November 2019
Quick facts
| Lead sponsor | Oklahoma State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 68 |
| Start date | 15 January 2019 |
| Primary completion | 15 November 2019 |
| Estimated completion | 22 November 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Resistance Exercise
- Aerobic Exercise — full drug profile →
Conditions studied
- Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →
- Menopause Related Conditions — all drugs for Menopause Related Conditions →
- Neuromuscular Function — all drugs for Neuromuscular Function →
- Aerobic Capacity — all drugs for Aerobic Capacity →
Sponsor
Oklahoma State University
Who can join
Adults 45 to 65, female only, with Cardiovascular Risk Factor or Menopause Related Conditions. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Given the heightened cardiovascular disease (CVD) risk in post-menopausal women, studies are needed to explore novel, feasible methods for reducing risk in this population. Based on prior data, primarily in other populations, progressive resistance training is a promising candidate. This project will test the effectiveness of a practical, progressive resistance training regimen for lowering numerous CVD risk factors compared to both aerobic training and no exercise in post-menopausal women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03752060
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Resistance Exercise
Trials testing the same drug.
- NCT07367854 — Diet Synergy in Muscle Protein Synthesis · NA · not yet recruiting
- NCT07526909 — Effect of Different Meal Types Given Before Exercise on Plasma Amino Acid Levels and Metabolic Control Parameters in Cla · NA · recruiting
- NCT07165106 — Effects of Resistance and Aerobic Exercises on Walking and Sarcopenic Parameters in Parkinson's Disease · NA · completed
- NCT06683547 — The Impact of Ketone Monoester Intake on Post-exercise Hormonal Responses After Resistance Exercise in Young Males · NA · completed
- NCT07133256 — Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease · NA · completed
Other recruiting trials for Cardiovascular Risk Factor
Currently open trials in the same condition.
- NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
- NCT06225544 — Lumasiran in Hyperoxalaemic Patients on Haemodialysis · Phase 2 · recruiting
- NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting
- NCT05887622 — The Potassium Supplementation Study · NA · recruiting
- NCT04962061 — A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors. · NA · recruiting
Other Oklahoma State University trials
Trials by the same sponsor.
- NCT06970457 — The Interaction of Body Composition, Sex Hormones and Exercise in Men · NA · recruiting
- NCT06840431 — Randomized Control Trial of the Co-Parenting for Resilience Program · NA · enrolling by invitation
- NCT05977192 — Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination · NA · completed
- NCT06518863 — Ultra-Processed Foods and Executive Function · NA · completed
- NCT06310603 — Determinants and Outcomes of High vs. Low Ultra-processed Feeding · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03752060 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oklahoma State University
- Last refreshed: 3 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03752060.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing